ABBVIE INC (ABBV) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:ABBV • US00287Y1091
225.42 USD
-0.22 (-0.1%)
Last: Feb 3, 2026, 03:59 PM
We assign a fundamental rating of 5 out of 10 to ABBV. ABBV was compared to 524 industry peers in the Biotechnology industry. While ABBV belongs to the best of the industry regarding profitability, there are concerns on its financial health. ABBV has a correct valuation and a medium growth rate. ABBV also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- ABBV had positive earnings in the past year.
- ABBV had a positive operating cash flow in the past year.
- Each year in the past 5 years ABBV has been profitable.
- Each year in the past 5 years ABBV had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of ABBV (1.75%) is better than 88.93% of its industry peers.
- With an excellent Return On Invested Capital value of 15.64%, ABBV belongs to the best of the industry, outperforming 96.18% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for ABBV is below the industry average of 18.09%.
- The 3 year average ROIC (13.67%) for ABBV is below the current ROIC(15.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
- ABBV has a better Profit Margin (3.94%) than 89.12% of its industry peers.
- In the last couple of years the Profit Margin of ABBV has declined.
- ABBV has a better Operating Margin (33.05%) than 97.14% of its industry peers.
- In the last couple of years the Operating Margin of ABBV has declined.
- Looking at the Gross Margin, with a value of 71.16%, ABBV belongs to the top of the industry, outperforming 82.06% of the companies in the same industry.
- ABBV's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
- ABBV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for ABBV remains at a similar level compared to 1 year ago.
- ABBV has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ABBV has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.44 indicates that ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
- ABBV has a Altman-Z score of 2.44. This is in the better half of the industry: ABBV outperforms 67.56% of its industry peers.
- The Debt to FCF ratio of ABBV is 3.49, which is a good value as it means it would take ABBV, 3.49 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 3.49, ABBV belongs to the best of the industry, outperforming 92.37% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.44 |
ROIC/WACC1.85
WACC8.47%
2.3 Liquidity
- ABBV has a Current Ratio of 0.72. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.72, ABBV is doing worse than 87.98% of the companies in the same industry.
- A Quick Ratio of 0.60 indicates that ABBV may have some problems paying its short term obligations.
- With a Quick ratio value of 0.60, ABBV is not doing good in the industry: 88.74% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
- ABBV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.09%.
- Measured over the past 5 years, ABBV shows a small growth in Earnings Per Share. The EPS has been growing by 2.51% on average per year.
- The Revenue has been growing slightly by 7.40% in the past year.
- Measured over the past years, ABBV shows a quite strong growth in Revenue. The Revenue has been growing by 11.11% on average per year.
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
3.2 Future
- The Earnings Per Share is expected to grow by 13.67% on average over the next years. This is quite good.
- The Revenue is expected to grow by 7.50% on average over the next years.
EPS Next Y0.09%
EPS Next 2Y19.77%
EPS Next 3Y17.02%
EPS Next 5Y13.67%
Revenue Next Year8.75%
Revenue Next 2Y9.23%
Revenue Next 3Y8.83%
Revenue Next 5Y7.5%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 23.85, the valuation of ABBV can be described as rather expensive.
- 94.08% of the companies in the same industry are more expensive than ABBV, based on the Price/Earnings ratio.
- ABBV's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.41.
- ABBV is valuated correctly with a Price/Forward Earnings ratio of 15.53.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ABBV indicates a rather cheap valuation: ABBV is cheaper than 95.80% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.64, ABBV is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.85 | ||
| Fwd PE | 15.53 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ABBV is valued cheaper than 94.85% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, ABBV is valued cheaper than 95.61% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.24 | ||
| EV/EBITDA | 16.38 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- ABBV has a very decent profitability rating, which may justify a higher PE ratio.
- ABBV's earnings are expected to grow with 17.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)276.12
PEG (5Y)9.5
EPS Next 2Y19.77%
EPS Next 3Y17.02%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 3.14%, ABBV has a reasonable but not impressive dividend return.
- ABBV's Dividend Yield is rather good when compared to the industry average which is at 1.12. ABBV pays more dividend than 99.05% of the companies in the same industry.
- ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.14% |
5.2 History
- The dividend of ABBV is nicely growing with an annual growth rate of 7.72%!
- ABBV has been paying a dividend for at least 10 years, so it has a reliable track record.
- ABBV has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.72%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
- ABBV pays out 489.69% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP489.69%
EPS Next 2Y19.77%
EPS Next 3Y17.02%
NYSE:ABBV (2/3/2026, 3:59:00 PM)
225.42
-0.22 (-0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-04 2026-02-04/bmo
Inst Owners75.04%
Inst Owner Change-2.58%
Ins Owners0.05%
Ins Owner Change-0.57%
Market Cap398.40B
Revenue(TTM)59.64B
Net Income(TTM)2.35B
Analysts78.38
Price Target249.66 (10.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.14% |
Yearly Dividend6.24
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years11
Div Non Decr Years11
Ex-Date01-16 2026-01-16 (1.73)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)-0.03%
PT rev (3m)2.89%
EPS NQ rev (1m)-20.83%
EPS NQ rev (3m)-20.17%
EPS NY rev (1m)-6.72%
EPS NY rev (3m)-5.75%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)0.58%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.85 | ||
| Fwd PE | 15.53 | ||
| P/S | 6.68 | ||
| P/FCF | 20.24 | ||
| P/OCF | 19.1 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.38 |
EPS(TTM)9.45
EY4.19%
EPS(NY)14.52
Fwd EY6.44%
FCF(TTM)11.14
FCFY4.94%
OCF(TTM)11.8
OCFY5.24%
SpS33.75
BVpS-1.49
TBVpS-52.38
PEG (NY)276.12
PEG (5Y)9.5
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROCE | 20.86% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.59% | ||
| ROICexgc | 572.43% | ||
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% | ||
| FCFM | 33% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 14.25% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 838.33% | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.44 |
F-Score7
WACC8.47%
ROIC/WACC1.85
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
EPS Next Y0.09%
EPS Next 2Y19.77%
EPS Next 3Y17.02%
EPS Next 5Y13.67%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
Revenue Next Year8.75%
Revenue Next 2Y9.23%
Revenue Next 3Y8.83%
Revenue Next 5Y7.5%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year-0.19%
EBIT Next 3Y15.91%
EBIT Next 5Y10.95%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / ABBV FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to ABBV.
What is the valuation status of ABBVIE INC (ABBV) stock?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (ABBV). This can be considered as Fairly Valued.
Can you provide the profitability details for ABBVIE INC?
ABBVIE INC (ABBV) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABBV stock?
The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 23.85 and the Price/Book (PB) ratio is -150.8.
What is the expected EPS growth for ABBVIE INC (ABBV) stock?
The Earnings per Share (EPS) of ABBVIE INC (ABBV) is expected to grow by 0.09% in the next year.